Lv1
10 积分 2024-02-28 加入
Abstract 4256: YH012, a novel bispecific anti-HER2 and TROP2 antibody-drug conjugate, exhibits potent antitumor efficacy
10小时前
求助中
Viral Agents Oncolytic for Human Tumors in Heterologous Host. Oncolytic Effect of Coxsackie B Viruses
2个月前
已关闭
Envafolimab: First Approval
10个月前
已完结
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
10个月前
已完结
Access to innovation through clinical trials and the national early access program for patients with lung cancer in France: focus on atezolizumab and durvalumab
10个月前
已完结
皖公网安备34019202002308
